Childhood Cancer Survivors Face Accelerated Aging Effects, Study Reveals

Surviving cancer as a child or young adult could potentially accelerate biological aging and impact cognitive function later in life, according to groundbreaking new research from the University of Rochester Medical Center.

The comprehensive study examined whether life-saving treatments such as chemotherapy and radiation might speed up the aging process at the cellular level. Researchers also sought to establish connections between this accelerated aging and cognitive challenges related to memory, focus and learning abilities.

In what represents one of the largest investigations of its kind, scientists analyzed blood samples from approximately 1,400 long-term cancer survivors who received treatment at St. Jude Children’s Research Hospital. The research team employed specialized “epigenetic clocks” — sophisticated tools that estimate biological age by examining chemical markers on DNA.

“Biological age differs from chronological age in that it reflects the accumulation of cellular damage over time, rather than simply how many years someone has been alive,” explained the researchers in their report. The majority of participants were survivors of acute lymphoblastic leukemia or Hodgkin lymphoma, and all were at least five years past their treatment, with some having survived for several decades.

As part of the study, participants underwent detailed neurocognitive assessments measuring attention span, memory capacity, and information processing speed. The results revealed significant correlations between biological age markers and cognitive performance.

Chemotherapy emerged as having the most profound impact on aging acceleration. The research suggests these powerful treatments can fundamentally alter DNA structure and induce widespread cellular damage, with effects potentially lasting years beyond the initial treatment period.

“These well-established aging-related biomarkers have previously been associated with neurocognitive impairment and decline in older non-cancer populations, particularly in cognitive domains related to aging and dementia, such as memory, attention and executive function,” the study noted.

Dr. Marc Siegel, senior medical analyst for Fox News, commented on the findings: “It’s no surprise to find out that young people with cancer who have chemo early in life are affected in terms of long-term aging. Chemo poisons and damages cellular function — hopefully the cancer cells more than normal cells, but there is a significant impact on normal cells as well.”

The research also identified a phenomenon known as “chemo brain,” which causes temporary difficulties with memory, concentration, word recall, and cognitive fog in many patients. More significantly, the study found that survivors showing markers of higher biological age demonstrated measurable difficulties with memory and attention tasks.

Lead study author AnnaLynn Williams, PhD, emphasized the importance of these findings for developing intervention strategies. “Young cancer survivors have many more decades of life to live,” Williams said in a press release. “If these accelerated aging changes are occurring early on and setting them on a different trajectory, the goal is to intervene to not only increase their lifespan, but improve their quality of life.”

The research team hopes these discoveries will help identify when accelerated aging begins, potentially allowing for earlier intervention to mitigate long-term cognitive effects. This could be particularly valuable for childhood cancer survivors, who face decades of life after treatment.

The researchers acknowledge several limitations to their study. They were unable to adjust for chronic health conditions or education levels because these factors are directly impacted by cancer treatment. Additionally, the study only examined survivors at a single point in time, making it difficult to establish direct causation between treatments and aging effects.

Despite these limitations, the findings published in the journal Nature Communications represent a significant advancement in understanding the long-term consequences of childhood cancer treatments. They highlight the need for continued research into supportive therapies that might counteract accelerated aging effects while maintaining the life-saving benefits of cancer treatment.

As survival rates for childhood cancers continue to improve, the medical community is increasingly focused on quality of life for survivors. This research provides valuable insight into potential intervention points to ensure these survivors not only live longer lives but healthier ones with improved cognitive function.